Scinai Immunotherapeutics Ltd.    SEC # 1611747

        

Click to view...

Registrant

About

Filings

Files

Relationships

Names

Topics

Web

Registrant
 SEC-Registered:  6/24/14   —   First EDGAR Filing:  11/13/14   –   Last Filing:  5/7/24 

Business Address      On:  5/7/24       [ Map ]		Mailing Address      On:  5/7/24       [ Map ]
Jerusalem Biopark, 2nd Floor Hadassah Ein Kerem Campus Jerusalem Israel

Phone #		Organized In		Fiscal-Year End		IRS #		SEC CIK		SEC File #
+972 8-9302529		Israel		12/31/yy		—		0001611747		001-37353

Market: Symbol:  Nasdaq: SCNI

In a Major Index:	NASDAQ Composite

Industry Classification
SIC:     Code      U.S. Industry      Through      Source      Filings-Review Office 2836 Biological Products, Except Diagnostic Substances 2024 SEC Office of Life Sciences

        

Management
Director   In   NY   Germain Mark 2023   Green Jay 2023   Laster Morris C 2023   Lowell George 2023   IN   Margolin Yael 2023   NJ   Moed Samuel J 2023   NJ   Raviv Adi 2023   Reichman Amir 2023   Rotman Avner 2023				Officer  Since  Most-Recent Title   In   Ben-Or Uri Chief Financial Officer 2023   Ben-Yedidia Tamar Chief Scientist 2023   Mark Elad Chief Operating Officer 2023   Reichman Amir Chief Executive Officer 2023

        

        

        

        

Securities
Market:  Symbol       (Prices)   Nasdaq:  SCNI   _________  Symbol source:  SEC  As of:  5/8/24  Before 9/14/23: Nasdaq:  BVXV		CUSIP, CINS or PPN       Description ← Symbol   Issuer Issue (Class or re: Filing — Name)      To 2024:   09073Q 09073Q·10·5     Spond ADS — ADR ← BVXV 09073Q·11·3     W Exp 05/15/202 09073Q·20·4     Sponsored ADS New _________  Classes source:  Form 13F Filings that list Section 13(f) Securities